Gliomatosis cerebri epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ed Putiz (talk | contribs)
nocaptcha
98 edits
Ed Putiz (talk | contribs)
nocaptcha
98 edits
Line 19: Line 19:
===Incidence===
===Incidence===
*The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/29464663|title=Incidence and survival of gliomatosis cerebri: a population-based cancer registration study|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
*The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/29464663|title=Incidence and survival of gliomatosis cerebri: a population-based cancer registration study|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Race===
===Race===
*There is no data on racial predilection for gliomatosis cerebri.
*There is no data on racial predilection for gliomatosis cerebri.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].


===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
*There is no data on regional and geographical predilection for gliomatosis cerebri.
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Developed Countries===

Revision as of 01:46, 19 September 2019

Gliomatosis cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gliomatosis cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gliomatosis cerebri epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gliomatosis cerebri epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gliomatosis cerebri epidemiology and demographics

CDC on Gliomatosis cerebri epidemiology and demographics

Gliomatosis cerebri epidemiology and demographics in the news

Blogs on Gliomatosis cerebri epidemiology and demographics

Directions to Hospitals Treating Gliomatosis cerebri

Risk calculators and risk factors for Gliomatosis cerebri epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1] Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2] The median age at diagnosis is 34 years.[3] Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.[2]

Epidemiology and Demographics

Incidence

  • Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1]

Age

  • Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2]
  • The median age at diagnosis is 34 years.[3]

Gender

  • Males are slightly more affected than females. The male to female ratio is approximately 1.5 to 1.[2]

Incidence

  • The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.[4]

Race

  • There is no data on racial predilection for gliomatosis cerebri.

Region

  • There is no data on regional and geographical predilection for gliomatosis cerebri.

Developed Countries

Developing Countries

References

  1. ↑ 1.0 1.1 Gliomatosis cerebri international registry. http://gcregistry.com/
  2. ↑ 2.0 2.1 2.2 2.3 Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
  3. ↑ 3.0 3.1 Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH; et al. (1998). "Gliomatosis cerebri: clinical features, treatment, and prognosis". Acta Neurochir (Wien). 140 (8): 755–62. PMID 9810441.
  4. ↑ "Incidence and survival of gliomatosis cerebri: a population-based cancer registration study".


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Gliomatosis_cerebri_epidemiology_and_demographics&oldid=1582228"